Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $4.06 on 9/23/25 after a major increase of 17.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 2930% of normal. The stock has risen 32.2% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Adverum Biotechnologies has a slightly negative Appreciation Score of 36 and a very low Power Rating of 5, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment